TEVA

YnetGlobal Channels

Sites & Sources

more channels

Contact

Tags

TEVA

Teva shares jump by 26% on Wall Street as its most promising drug shows exceptional trial results

Duvakitug, a treatment for colitis and Crohn's disease, surpassed expectations and positions Teva to compete in the $28 billion global inflammatory bowel disease market

Sophie Shulman | 12.17.24

ריצ'רד פרנסיס, נשיא ומנכ"ל טבע, במפגש העיתונאים

Teva Q2 results stronger than expected

The pharmaceutical company reports revenue of $4.2 billion and earnings of 61 cents per share. Austedo, Teva's strongest drug, designed to treat Dyskinesia, grew by 32% and generated revenues of $407 million

Sophie Shulman, Calcalist | 08.01.24

טבע

Teva to pay US millions in price-fixing settlement

Israeli pharmaceutical company set to pay $225 million in several installments over the next five years after court finds it and other companies responsible for rising drug prices - by up to 1000%

Sophie Shulman/Calcalist | 08.22.23

Israel's Teva agrees to pay $126 mln to US hospitals over opioids

Pharmaceutical says it has been sued by about 500 U.S. hospitals and other healthcare providers over sale of brand-name fentanyl-based drug Fentora

08.03.23

Teva office building

Teva to pay $193 million to Nevada in opioid case

Pharmaceutical company's spokesperson confirms settlement following claims Teva's practices in the U.S. led to widespread opioid addiction; payment plan will last from 2024 up to 2043

Reuters | 06.08.23

Previous Articles

Hot Tags

Today

This Week

This Month

Abraham Accords Academia Aesthetic procedure AI Amine Ayoub anti-Israeli antisemitic threats Antisemitism Arab Israelis Aryeh Deri

Hot Tags

Today

This Week

This Month

Abraham Accords Academia Aesthetic procedure AI Amine Ayoub anti-Israeli antisemitic threats Antisemitism Arab Israelis Aryeh Deri

""